|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jensen MB, Ejlertsen B, Mouridsen HT and
Christiansen P; Danish Breast Cancer Cooperative Group, .
Improvements in breast cancer survival between 1995 and 2012 in
Denmark: The importance of earlier diagnosis and adjuvant
treatment. Acta Oncol. 2 Suppl 55:S24–S35. 2016. View Article : Google Scholar
|
|
3
|
Lukong KE: Understanding breast cancer –
The long and winding road. BBA Clin. 7:64–77. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
O'Reilly EA, Gubbins L, Sharma S, Tully R,
Guang MH, Weiner-Gorzel K, McCaffrey J, Harrison M, Furlong F, Kell
M and McCann A: The fate of chemoresistance in triple negative
breast cancer (TNBC). BBA Clin. 3:257–275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miah S, Banks CA, Adams MK, Florens L,
Lukong KE and Washburn MP: Advancement of mass spectrometry-based
proteomics technologies to explore triple negative breast cancer.
Mol Biosyst. 13:42–55. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Denkert C, Liedtke C, Tutt A and von
Minckwitz G: Molecular alterations in triple-negative breast
cancer-the road to new treatment strategies. Lancet. 389:2430–2442.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kannouche P, Mauffrey P, Pinon-Lataillade
G, Mattei MG, Sarasin A, Daya-Grosjean L and Angulo JF: Molecular
cloning and characterization of the human KIN17 cDNA encoding a
component of the UVC response that is conserved among metazoans.
Carcinogenesis. 21:1701–1710. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miccoli L, Frouin I, Novac O, Di Paola D,
Harper F, Zannis-Hadjopoulos M, Maga G, Biard DS and Angulo JF: The
human stress-activated protein kin17 belongs to the multiprotein
DNA replication complex and associates in vivo with mammalian
replication origins. Mol Cell Biol. 25:3814–3830. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pinon-Lataillade G, Masson C,
Bernardino-Sgherri J, Henriot V, Mauffrey P, Frobert Y, Araneda S
and Angulo JF: KIN17 encodes an RNA-binding protein and is
expressed during mouse spermatogenesis. J Cell Sci. 117:3691–3702.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng T, Gao H, Yu P, He H, Ouyang X, Deng
L and Zhang Y: Up-regulation of kin17 is essential for
proliferation of breast cancer. Plos One. 6:e253432011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu M, Zhang Z, Yu H, Xue C, Yuan K, Miao M
and Shi H: KIN enhances stem cell-like properties to promote
chemoresistance in colorectal carcinoma. Biochem Biophys Res
Commun. 448:63–69. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Huang S, Gao H, Wu K, Ouyang X,
Zhu Z, Yu X and Zeng T: Upregulation of KIN17 is associated with
non-small cell lung cancer invasiveness. Oncol Lett. 13:2274–2280.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kou WZ, Xu SL, Wang Y, Wang LW, Wang L,
Chai XY and Hua QL: Expression of Kin17 promotes the proliferation
of hepatocellular carcinoma cells in vitro and in vivo. Oncol Lett.
8:1190–1194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hammond ME, Hayes DF, Dowsett M, Allred
DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS,
Hayes M, et al: American society of clinical oncology/college of
american pathologists guideline recommendations for
immunohistochemical testing of estrogen and progesterone receptors
in breast cancer. Arch Pathol Lab Med. 134:907–922. 2010.PubMed/NCBI
|
|
15
|
Kohler BA, Sherman RL, Howlader N, Jemal
A, Ryerson AB, Henry KA, Boscoe FP, Cronin KA, Lake A, Noone AM, et
al: Annual report to the nation on the status of cancer, 1975-2011,
featuring incidence of breast cancer subtypes by race/ethnicity,
poverty, and state. J Natl Cancer Inst. 107:djv0482015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qiu J, Xue X, Hu C, Xu H, Kou D, Li R and
Li M: Comparison of clinicopathological features and prognosis in
triple-negative and non-triple negative breast cancer. J Cancer.
7:167–173. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thornberry NA and Lazebnik Y: Caspases:
Enemies within. Science. 281:1312–1316. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Earnshaw WC, Martins LM and Kaufmann SH:
Mammalian caspases: Structure, activation, substrates, and
functions during apoptosis. Annu Rev Biochem. 68:383–424. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boccardo F and Rubagotti A: Switching to
aromatase inhibitors in early breast cancer. Lancet. 369:533–535.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mirkin S and Pickar JH: Selective estrogen
receptor modulators (SERMs): A review of clinical data. Maturitas.
80:52–57. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Montero JC, Ocaña A, Abad M, Ortiz-Ruiz
MJ, Pandiella A and Esparís-Ogando A: Expression of Erk5 in early
stage breast cancer and association with disease free survival
identifies this kinase as a potential therapeutic target. PLoS One.
4:e55652009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vyas S, Matic I, Uchima L, Rood J, Zaja R,
Hay RT, Ahel I and Chang P: Family-wide analysis of
poly(ADP-ribose) polymerase activity. Nat Commun. 5:44262014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lux MP, Janni W, Hartkopf AD, Nabieva N,
Taran FA, Overkamp F, Kolberg HC, Hadji P, Tesch H, Ettl J, et al:
Update breast cancer 2017-implementation of novel therapies.
Geburtshilfe Frauenheilkd. 77:1281–1290. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Okuma HS and Yonemori K: BRCA gene
mutations and poly(ADP-Ribose) polymerase inhibitors in
triple-negative breast cancer. Adv Exp Med Biol. 1026:271–286.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hamaoka S, Kitazawa N, Nara K, Sasaki A,
Kamada A and Okabe T: Selective estrogen receptor modulator. US:
pp. 469–476. 2011
|
|
26
|
Jameera Begam A, Jubie S and Nanjan MJ:
Estrogen receptor agonists/antagonists in breast cancer therapy: A
critical review. Bioorg Chem. 71:257–274. 2017. View Article : Google Scholar : PubMed/NCBI
|
